While some NIH study sections will resume, advisory council meetings, which make final funding decisions, seem to still be ...
As biosimilar versions of a big-selling Johnson & Johnson medicine reach the U.S. market, the health care giant accused one ...
Hi! Good to see ya. An ER doctor in Chicago told the New York Times last week that he sees “Croc-specific injuries” once a ...
Patrizia Cavazzoni, formerly the top regulator of the drug division of the FDA, will join Pfizer as chief medical officer.
An approval for the first drug for a rare lipid storage disease, some FDA workers rehired, and other biotech news of the day ...
A small study on Covid vaccine safety has sparked an online tempest — and highlighted the conundrum faced by some scientists.
The United States has joined a WHO-led flu vaccine meeting, despite the Trump administration's plans to withdraw from the ...
The hiring of a former top FDA official amplifies "revolving door" criticism at the worst possible time, STAT's Adam ...
If the Trump administration truly wants to reduce waste and fraud in government spending, they need some basic lessons from ...
A patient’s family chose comfort care, and my first thought was, ‘One less.’”: How lack of sleep shreds doctors’ empathy.
The Trump administration has started quietly rehiring some of the U.S. Food and Drug Administration employees it fired last week, according to nine agency sources, shortly after letting them go in a ...
The Trump administration has started quietly re-hiring some of the FDA employees that it fired last week in a process that insiders called abrupt and haphazard, STAT’s Lizzy Lawrence reports. The ...